Research workbench
LMO4-LIM2 in complex with DEAF1 (404-418)
Analyse LMO4-LIM2 in complex with DEAF1 (404-418) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 2MBV
- Type
- protein
- Length
- 96 residues
- Chains
- 1
- Method
- solution nmr
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Fusion protein of lim domain transcription factor LMO4 (77- 147) and DEAF1 (404-418)
- UniProt
- P61969, Q9Z1T5
- Ligands
- ZN
Structure
solution nmr · 1 distinct chain · 0% helix, 23% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Fusion protein of lim domain transcription factor LMO4 (77- 147) and DEAF1 (404-418) | protein | 96 | 0% helix, 23% strand | P61969, Q9Z1T5 |
Ligands and binding sites
- ZN · Zinc ion · metal · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 2MBV · LMO4-LIM2 in complex with DEAF1 (404-418) · the same entry in another collection · chain A against A, TM-score 1.00
- P61969 · AlphaFold monomer V2.0 prediction for lim domain transcription factor LMO4 (P61969) · a predicted model of the same protein · chain A against A, TM-score 0.62
- Q9Z1T5 · AlphaFold monomer V2.0 prediction for deformed epidermal autoregulatory factor 1 homolog… · a predicted model of the same protein · chain A against A, TM-score 0.27
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P61969
- Every structure of UniProt Q9Z1T5
- Elsewhere: RCSB PDB 2MBV · PDBe 2MBV · UniProt P61969 · UniProt Q9Z1T5
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.